Christopher Heery
Chief Tech/Sci/R&D Officer bij ARCELLX, INC.
Vermogen: 621 638 $ op 31-03-2024
Actieve functies van Christopher Heery
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ARCELLX, INC. | Chief Tech/Sci/R&D Officer | 01-04-2021 | - |
Loopbaan van Christopher Heery
Eerdere bekende functies van Christopher Heery
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PRECISION BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | 14-05-2019 | 23-04-2021 |
National Cancer Institute
 National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Corporate Officer/Principal | - | - |
| BAVARIAN NORDIC A/S | Chief Tech/Sci/R&D Officer | 28-09-2016 | - |
Opleiding van Christopher Heery
| Duke University | Undergraduate Degree |
| Brody School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
| Denemarken | 2 |
Operationeel
| Chief Tech/Sci/R&D Officer | 3 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 3 |
| Miscellaneous | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| PRECISION BIOSCIENCES, INC. | Health Technology |
| BAVARIAN NORDIC A/S | Health Technology |
| ARCELLX, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
National Cancer Institute
National Cancer Institute Investment Trusts/Mutual FundsMiscellaneous National Cancer Institute provides healthcare services. It specializes in different cancer treatment such as adrenocortical carcinoma, anal cancer, appendix cancer, skin cancer, breast cancer, cardiac tumors, endometrial cancer, and gallbladder cancer. The company was founded in March 1937 and is headquartered in Bethesda, MD. | Miscellaneous |
- Beurs
- Insiders
- Christopher Heery
- Ervaring
